REQUEST A DEMO
Total
USD $0.00
Search more companies

Daewoong Pharmaceutical (Thailand) Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Daewoong Pharmaceutical (Thailand) Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Daewoong Pharmaceutical (Thailand) Company Limited is based in Thailand, with the head office in Bangkok , Special Governed District of. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on June 01, 2026. The total number of employees is currently 5 (2024). In its most recent financial highlights, the company reported a net sales revenue drop of 8.71% in 2024. Its’ total assets recorded a negative growth of 32.44%. The net profit margin of Daewoong Pharmaceutical (Thailand) Company Limited decreased by 0.46% in 2024.

Headquarters
1550 New Phetchaburi Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10400

Contact Details: Purchase the Daewoong Pharmaceutical (Thailand) Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Daewoong Pharmaceutical (Thailand) Company Limited report to view the information.
Financial Auditors:
Purchase the Daewoong Pharmaceutical (Thailand) Company Limited report to view the information.
Incorporation Date:
June 01, 2026
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Daewoong Pharmaceutical (Thailand) Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-8.71%
Total Operating Revenue
-7.8%
Operating Profit
-21.66%
EBITDA
-21.66%
Net Profit/Loss for the Period
-26.4%
Total Assets
-32.44%
Total Equity
20.16%
Operating Profit Margin
-0.4%
Net Profit Margin
-0.46%
Return on Equity (ROE)
2.14%
Quick Ratio
-0.02%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?